KPV
Inflammation, calmed.
A tripeptide derived from alpha-MSH with potent anti-inflammatory and immunomodulatory action — inhibiting pro-inflammatory cytokines across delivery ORAL SQ TOPICAL
Anti-inflammatory, engineered.
A tripeptide derived from alpha-melanocyte-stimulating hormone that reduces inflammation across autoimmune, GI, and dermatologic conditions.
- Patients with chronic inflammatory conditions (IBD, autoimmune)
- Anyone with persistent skin inflammation (eczema, psoriasis)
- Athletes addressing inflammation-driven recovery issues
Broad Anti-Inflammatory Action
Inhibits pro-inflammatory cytokines and reduces oxidative stress. Inflammation tends to soften across systems.
Gastrointestinal Inflammation
Studied for IBD and chronic GI inflammatory conditions. Digestive flares and comfort often improve.
Skin & Dermatologic Conditions
Topical use targets eczema, psoriasis, and dermatoses. Visible redness and irritation often calm.
Wound Healing Support
Promotes tissue repair through anti-inflammatory mechanisms. Tissue repair accelerates.
Flexible Delivery for Clinical Context
Available as injection, capsule, or cream. Match delivery to systemic or localized goals.
Initial inflammation reduction begins.
Sustained symptom improvement emerges.
Foundation of inflammation resilience built.
- Physician-supervised by Thomas Nabity, MD
- 503A / 503B compounding pharmacy sourcing
- Pre-protocol labs, body composition, and review
- 30 / 60 / 90-day follow-up with companion support